+91 44 2496 8000 info@caplinpoint.net

CAPLIN STERILES GETS USFDA APPROVAL FOR NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION, INFUSION BAGS

Chennai, Oct 23rd , 2025: Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection, 20 mg/200 mL (0.1 mg/mL)…

Read More ยป